https://biojungbomoa.com/programs/keytruda2026-09-10weekly0.9https://biojungbomoa.com/programs/opdivo2026-09-10weekly0.9https://biojungbomoa.com/programs/herceptin2026-09-10weekly0.9https://biojungbomoa.com/programs/imfinzi2026-09-10weekly0.9https://biojungbomoa.com/programs/tecentriq2026-09-10weekly0.9https://biojungbomoa.com/programs/humira2026-09-10weekly0.9https://biojungbomoa.com/programs/darzalex2026-09-10weekly0.9https://biojungbomoa.com/programs/semaglutide2026-09-10weekly0.9https://biojungbomoa.com/programs/dupixent2026-09-10weekly0.9https://biojungbomoa.com/programs/tirzepatide2026-09-10weekly0.9https://biojungbomoa.com/programs/eylea2026-09-10weekly0.9https://biojungbomoa.com/programs/trodelvy2026-09-10weekly0.9https://biojungbomoa.com/programs/enhertu2026-09-10weekly0.9https://biojungbomoa.com/programs/enbrel2026-09-10weekly0.9https://biojungbomoa.com/programs/lucentis2026-09-10weekly0.9https://biojungbomoa.com/programs/cosentyx2026-09-10weekly0.9https://biojungbomoa.com/programs/tevimbra2026-09-10weekly0.9https://biojungbomoa.com/programs/padcev2026-09-10weekly0.9https://biojungbomoa.com/programs/stelara2026-09-10weekly0.9https://biojungbomoa.com/programs/brentuximab-vedotin2026-09-10weekly0.9https://biojungbomoa.com/programs/kadcyla2026-09-10weekly0.9https://biojungbomoa.com/programs/disitamab-vedotin2026-09-10weekly0.9https://biojungbomoa.com/programs/repatha2026-09-10weekly0.9https://biojungbomoa.com/programs/tecvayli2026-09-10weekly0.9https://biojungbomoa.com/programs/skyrizi2026-09-10weekly0.9https://biojungbomoa.com/programs/ebglyss2026-09-10weekly0.9https://biojungbomoa.com/programs/praluent2026-09-10weekly0.9https://biojungbomoa.com/programs/polatuzumab-vedotin2026-09-10weekly0.9https://biojungbomoa.com/programs/columvi2026-09-10weekly0.9https://biojungbomoa.com/programs/tremfya2026-09-10weekly0.9https://biojungbomoa.com/programs/blenrep2026-09-10weekly0.9https://biojungbomoa.com/programs/leqvio2026-09-10weekly0.9https://biojungbomoa.com/programs/yescarta2026-09-10weekly0.9https://biojungbomoa.com/programs/bimzelx2026-09-10weekly0.9https://biojungbomoa.com/programs/epkinly2026-09-10weekly0.9https://biojungbomoa.com/programs/vabysmo2026-09-10weekly0.9https://biojungbomoa.com/programs/datroway2026-09-10weekly0.9https://biojungbomoa.com/programs/kymriah2026-09-10weekly0.9https://biojungbomoa.com/programs/vyvgart2026-09-10weekly0.9https://biojungbomoa.com/programs/amtagvi2026-09-10weekly0.9https://biojungbomoa.com/programs/tezspire2026-09-10weekly0.9https://biojungbomoa.com/programs/imdelltra2026-09-10weekly0.9https://biojungbomoa.com/programs/leqembi2026-09-10weekly0.9https://biojungbomoa.com/programs/ziihera2026-09-10weekly0.9https://biojungbomoa.com/programs/elahere2026-09-10weekly0.9https://biojungbomoa.com/programs/carvykti2026-09-10weekly0.9https://biojungbomoa.com/programs/zolgensma2026-09-10weekly0.9https://biojungbomoa.com/programs/imaavy2026-09-10weekly0.9https://biojungbomoa.com/programs/vyloy2026-09-10weekly0.9https://biojungbomoa.com/programs/lynozyfic2026-09-10weekly0.9https://biojungbomoa.com/programs/kisunla2026-09-10weekly0.9https://biojungbomoa.com/programs/tisotumab-vedotin2026-09-10weekly0.9https://biojungbomoa.com/programs/emrelis2026-09-10weekly0.9https://biojungbomoa.com/programs/elevidys2026-09-10weekly0.9https://biojungbomoa.com/programs/adstiladrin2026-09-10weekly0.9https://biojungbomoa.com/programs/casgevy2026-09-10weekly0.9https://biojungbomoa.com/programs/roctavian2026-09-10weekly0.9https://biojungbomoa.com/programs/luxturna2026-09-10weekly0.9https://biojungbomoa.com/programs/hemgenix2026-09-10weekly0.9https://biojungbomoa.com/programs/lenmeldy2026-09-10weekly0.9https://biojungbomoa.com/programs/lyfgenia2026-09-10weekly0.9https://biojungbomoa.com/programs/avastin2026-09-10weekly0.9https://biojungbomoa.com/programs/rituxan2026-09-10weekly0.9https://biojungbomoa.com/programs/erbitux2026-09-10weekly0.9https://biojungbomoa.com/programs/ipilimumab2026-09-10weekly0.9https://biojungbomoa.com/programs/remicade2026-09-10weekly0.9https://biojungbomoa.com/programs/pertuzumab2026-09-10weekly0.9https://biojungbomoa.com/programs/tremelimumab2026-09-10weekly0.9https://biojungbomoa.com/programs/tocilizumab2026-09-10weekly0.9https://biojungbomoa.com/programs/obinutuzumab2026-09-10weekly0.9https://biojungbomoa.com/programs/toripalimab2026-09-10weekly0.9https://biojungbomoa.com/programs/cemiplimab2026-09-10weekly0.9https://biojungbomoa.com/programs/ramucirumab2026-09-10weekly0.9https://biojungbomoa.com/programs/abatacept2026-09-10weekly0.9https://biojungbomoa.com/programs/blinatumomab2026-09-10weekly0.9https://biojungbomoa.com/programs/vedolizumab2026-09-10weekly0.9https://biojungbomoa.com/programs/ofatumumab2026-09-10weekly0.9https://biojungbomoa.com/programs/golimumab2026-09-10weekly0.9https://biojungbomoa.com/programs/ivonescimab2026-09-10weekly0.9https://biojungbomoa.com/programs/relatlimab2026-09-10weekly0.9https://biojungbomoa.com/programs/shr-a18112026-09-10weekly0.9https://biojungbomoa.com/programs/certolizumab-pegol2026-09-10weekly0.9https://biojungbomoa.com/programs/dostarlimab2026-09-10weekly0.9https://biojungbomoa.com/programs/ocrelizumab2026-09-10weekly0.9https://biojungbomoa.com/programs/isatuximab2026-09-10weekly0.9https://biojungbomoa.com/programs/elranatamab2026-09-10weekly0.9https://biojungbomoa.com/programs/mepolizumab2026-09-10weekly0.9https://biojungbomoa.com/programs/ixekizumab2026-09-10weekly0.9https://biojungbomoa.com/programs/amivantamab2026-09-10weekly0.9https://biojungbomoa.com/programs/mosunetuzumab2026-09-10weekly0.9https://biojungbomoa.com/programs/tralokinumab2026-09-10weekly0.9https://biojungbomoa.com/programs/talquetamab2026-09-10weekly0.9https://biojungbomoa.com/programs/patritumab-deruxtecan2026-09-10weekly0.9https://biojungbomoa.com/programs/nemolizumab2026-09-10weekly0.9https://biojungbomoa.com/programs/odronextamab2026-09-10weekly0.9https://biojungbomoa.com/programs/ifinatamab-deruxtecan2026-09-10weekly0.9https://biojungbomoa.com/programs/rgx-3142026-09-10weekly0.9https://biojungbomoa.com/programs/tecartus2026-09-10weekly0.9https://biojungbomoa.com/programs/luveltamab-tazevibulin2026-09-10weekly0.9https://biojungbomoa.com/programs/xolair2026-09-10weekly0.9https://biojungbomoa.com/programs/fam-trastuzumab-deruxtecan-nxki2026-09-02weekly0.8https://biojungbomoa.com/programs/tisotumab-vedotin-tftv2026-09-02weekly0.8https://biojungbomoa.com/programs/hepatitis-b-vaccine-recombinant2026-09-02weekly0.7https://biojungbomoa.com/programs/19-t2-28z1xx-trac-t-cell2026-09-02weekly0.7https://biojungbomoa.com/programs/measles-mumps-rubella-vaccine-live2026-09-02weekly0.7https://biojungbomoa.com/programs/antibody-drug-conjugate-adc2026-09-02weekly0.7https://biojungbomoa.com/programs/factor-ix-fix2026-09-02weekly0.7https://biojungbomoa.com/programs/brentuximab-vedotin-recombinant2026-09-02weekly0.7https://biojungbomoa.com/programs/chimeric-antigen-receptor-t-cells-car-t-targeting-bcma2026-09-02weekly0.7https://biojungbomoa.com/programs/brentuximab-vedotin-bv2026-09-02weekly0.7https://biojungbomoa.com/programs/polatuzumab-vedotin-lyophilized2026-09-02weekly0.7https://biojungbomoa.com/programs/mab-her-2-herceptin2026-09-02weekly0.7https://biojungbomoa.com/programs/19-t2-28z1xx-car-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/abiraterone-acetate-aa2026-09-02weekly0.7https://biojungbomoa.com/programs/polatuzumab-vedotin-pv2026-09-02weekly0.7https://biojungbomoa.com/programs/gene-expression-analysis2026-09-02weekly0.7https://biojungbomoa.com/programs/autologous-cd19-directed-chimeric-antigen-receptor-car-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/patritumab-deruxtecan-fixed-dose2026-09-02weekly0.7https://biojungbomoa.com/programs/trastuzumab-deruxtecan2026-09-02weekly0.7https://biojungbomoa.com/programs/patritumab-deruxtecan-up-titration2026-09-02weekly0.7https://biojungbomoa.com/programs/trastuzumab-deruxtecan-t-dxd2026-09-02weekly0.7https://biojungbomoa.com/programs/asparaginase-erwinia-chrysanthemi-recombinant-rywn2026-09-02weekly0.7https://biojungbomoa.com/programs/trastuzumab-deruxtecan-t-dxd-monotherapy2026-09-02weekly0.7https://biojungbomoa.com/programs/kyv-101-biological-1-10-8-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/kyv-101-biological-0-33-10-8-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/anti-b-cell-maturation-antigen-bcma-chimeric-antigen-receptors-cars-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/cd19-car-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/trastuzumab-emtansine2026-09-02weekly0.7https://biojungbomoa.com/programs/e7-t-cell-receptor-tcr2026-09-02weekly0.7https://biojungbomoa.com/programs/trastuzumab-deruxtecan-t-dxd-with-pyrotinib2026-09-02weekly0.7https://biojungbomoa.com/programs/trastuzumab-deruxtecan-ds-8201a2026-09-02weekly0.7https://biojungbomoa.com/programs/trastuzumab-deruxtecan-t-dxd-ds-8201a2026-09-02weekly0.7https://biojungbomoa.com/programs/induction-with-brentuximab-vedotin-bv2026-09-02weekly0.7https://biojungbomoa.com/programs/23-valent-polysaccharide-pneumococcal-vaccine2026-09-02weekly0.7https://biojungbomoa.com/programs/seneca-valley-virus-biological-agent2026-09-02weekly0.7https://biojungbomoa.com/programs/cd19-car-t2026-09-02weekly0.7https://biojungbomoa.com/programs/chimeric-antigen-receptor-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/brentuximab-vedotin-genetical-recombination2026-09-02weekly0.7https://biojungbomoa.com/programs/anti-b7-h3-chimeric-antigen-receptor-t-cell-car-t-cell-injection-tx1032026-09-02weekly0.7https://biojungbomoa.com/programs/anti-cd19-car-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/allogeneic-stem-cell-transplant2026-09-02weekly0.7https://biojungbomoa.com/programs/chimeric-antigen-receptor2026-09-02weekly0.7https://biojungbomoa.com/programs/disitamab-vedotin-rc48-plus-tratuzumab2026-07-31weekly0.7https://biojungbomoa.com/programs/tcr-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/car-t-cell-immunotherapy2026-09-02weekly0.7https://biojungbomoa.com/programs/interferon-alfa-2b2026-09-02weekly0.7https://biojungbomoa.com/programs/ado-trastuzumab-t-emtansine-t-dm12026-09-02weekly0.7https://biojungbomoa.com/programs/metoprolol2026-08-19weekly0.7https://biojungbomoa.com/programs/control-drug-trastuzumab-emtansine-kadcyla-t-dm12026-09-02weekly0.7https://biojungbomoa.com/programs/natural-killer-nk-lymphocytes2026-08-19weekly0.7https://biojungbomoa.com/programs/recombinant-interferon-alfa-2b2026-09-02weekly0.7https://biojungbomoa.com/programs/propranolol2026-07-31weekly0.7https://biojungbomoa.com/programs/initial-dose-dose-group-12026-09-02weekly0.7https://biojungbomoa.com/programs/natural-killer-nk-cell-infusion2026-09-02weekly0.7https://biojungbomoa.com/programs/gemtuzumab-ozogamicin2026-09-02weekly0.7https://biojungbomoa.com/programs/belantamab-mafodotin2026-09-02weekly0.7https://biojungbomoa.com/programs/cd19-targeted-chimeric-antigen-receptor-car-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/stem-cell-infusion2026-09-02weekly0.7https://biojungbomoa.com/programs/multi-epitope-me-t-cell-receptor-alternate-reading-frame-protein-tarp-vaccine2026-09-02weekly0.7https://biojungbomoa.com/programs/zm-02-selected-dose2026-09-02weekly0.7https://biojungbomoa.com/programs/zm-02-high-dose2026-09-02weekly0.7https://biojungbomoa.com/programs/sacituzumab-tirumotecan-sac-tmt2026-09-02weekly0.7https://biojungbomoa.com/programs/taxol2026-08-19weekly0.7https://biojungbomoa.com/programs/chimeric-antigen-receptor-t-cell-treatment2026-08-19weekly0.7https://biojungbomoa.com/programs/chimeric-antigen-receptor-t-cell2026-08-19weekly0.7https://biojungbomoa.com/programs/stem-cells2026-07-13weekly0.7https://biojungbomoa.com/programs/valproic-acid2026-07-12weekly0.7https://biojungbomoa.com/programs/topotecan-hydrochloride2026-09-02weekly0.7https://biojungbomoa.com/programs/target-therapy2026-09-02weekly0.7https://biojungbomoa.com/programs/ethanol2026-09-02weekly0.7https://biojungbomoa.com/programs/induction-therapy2026-09-02weekly0.7https://biojungbomoa.com/programs/autologous-car-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/injection-of-scaav2-p1nd4v2-1-0-x10e11vg-higher2026-09-02weekly0.7https://biojungbomoa.com/programs/injection-of-scaav2-p1nd4v2-2-4-x10e10vg-high2026-09-02weekly0.7https://biojungbomoa.com/programs/injection-of-scaav2-p1nd4v2-5-81-x10e9-vg-med2026-09-02weekly0.7https://biojungbomoa.com/programs/injection-of-scaav2-p1nd4v2-1-18x10e9-vg-low2026-09-02weekly0.7https://biojungbomoa.com/programs/ado-trastuzumab-emtansine-t-dm12026-09-02weekly0.7https://biojungbomoa.com/programs/multi-epitope-me-t-cell-receptor-g-alternate-reading-frame-protein-tarp-vaccine2026-08-19weekly0.7https://biojungbomoa.com/programs/oxycodone-hydrochloride2026-07-18weekly0.7https://biojungbomoa.com/programs/morphine-sulfate2026-07-18weekly0.7https://biojungbomoa.com/programs/methadone-hydrochloride2026-07-18weekly0.7https://biojungbomoa.com/programs/immune-evaluation2026-07-18weekly0.7https://biojungbomoa.com/programs/gemcitabin2026-07-18weekly0.7https://biojungbomoa.com/programs/epidermal-growth-factor-receptor-egfrv-iii-chimeric-antigen-receptor-car-transduced-pbl2026-07-13weekly0.7https://biojungbomoa.com/programs/breast-cancer-cohort2026-07-13weekly0.7https://biojungbomoa.com/programs/e6-t-cell-receptor-tcr2026-07-12weekly0.7https://biojungbomoa.com/programs/atorvastatin2026-07-12weekly0.7https://biojungbomoa.com/programs/allopurinol2026-07-12weekly0.7https://biojungbomoa.com/programs/checkpoint-inhibitor-immune2026-09-02weekly0.7https://biojungbomoa.com/programs/oncolytic-virus-injection-rt-012026-09-02weekly0.7https://biojungbomoa.com/programs/omega-3-acid-ethyl-esters2026-09-02weekly0.7https://biojungbomoa.com/programs/ciprofloxacin2026-09-02weekly0.7https://biojungbomoa.com/programs/cytokine-induced-killer-cell2026-09-02weekly0.7https://biojungbomoa.com/programs/haploidentical-hematopoietic-cell-transplantation2026-09-02weekly0.7https://biojungbomoa.com/programs/tcr-t-cells-mdg10152026-09-02weekly0.7https://biojungbomoa.com/programs/lymphodepletion2026-09-02weekly0.7https://biojungbomoa.com/programs/levetiracetam2026-09-02weekly0.7https://biojungbomoa.com/programs/chimeric-antigen-receptor-car-t-cell-therapy2026-09-02weekly0.7https://biojungbomoa.com/programs/glembatumumab-vedotin-and-pd-1-targeted-checkpoint-inhibitor-nivolumab-or-pembrolizumab2026-09-02weekly0.7https://biojungbomoa.com/programs/zidovudine2026-08-19weekly0.7https://biojungbomoa.com/programs/interleukin2026-08-19weekly0.7https://biojungbomoa.com/programs/tcr-t2026-08-19weekly0.7https://biojungbomoa.com/programs/cd19-targeted-car-t-cells2026-08-19weekly0.7https://biojungbomoa.com/programs/pneumococcal-conjugate-vaccine2026-07-18weekly0.7https://biojungbomoa.com/programs/pegylated-asparaginase2026-07-18weekly0.7https://biojungbomoa.com/programs/ps-3412026-07-18weekly0.7https://biojungbomoa.com/programs/lung-cancer-cohort2026-07-18weekly0.7https://biojungbomoa.com/programs/gene-modified-therapy2026-07-13weekly0.7https://biojungbomoa.com/programs/concurrent-chemoradiation2026-07-13weekly0.7https://biojungbomoa.com/programs/chlorotoxin-eq-cd28-cd3zeta-cd19t-expressing-car-t-lymphocytes-via-ict-delivery2026-07-12weekly0.7https://biojungbomoa.com/programs/tamoxifen-citrate2026-07-12weekly0.7https://biojungbomoa.com/programs/chlorotoxin-eq-cd28-cd3zeta-cd19t-expressing-car-t-lymphocytes-via-ict-icv-dual-delivery2026-07-12weekly0.7https://biojungbomoa.com/programs/edetate-calcium-disodium2026-09-02weekly0.7https://biojungbomoa.com/programs/asct2026-09-02weekly0.7https://biojungbomoa.com/programs/gene-modified-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/trastuzumab-emtansine-t-dm12026-09-02weekly0.7https://biojungbomoa.com/programs/interferon-alpha2026-08-19weekly0.7https://biojungbomoa.com/programs/oncolytic-virus-injection-idov-safetm2026-08-19weekly0.7https://biojungbomoa.com/programs/m-cenk-activated-nk-cells2026-08-19weekly0.7https://biojungbomoa.com/programs/dendritic-cell-vaccine-therapy2026-08-19weekly0.7https://biojungbomoa.com/programs/proleukin2026-08-19weekly0.7https://biojungbomoa.com/programs/recombinant-interferon-alfa2026-08-19weekly0.7https://biojungbomoa.com/programs/at101-anti-cd19-chimeric-antigen-receptor-t-cell2026-08-19weekly0.7https://biojungbomoa.com/programs/naltrexone2026-07-18weekly0.7https://biojungbomoa.com/programs/recombinant-oncolytic-hsv-2-therapeutic-injecta-vero-cell-for-human-use-rhsv2hgm-csf2026-09-02weekly0.7https://biojungbomoa.com/programs/natural-killer-cell-infusion2026-09-02weekly0.7https://biojungbomoa.com/programs/allogeneic-nk-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/trimethoprim-sulfamethoxazole2026-09-02weekly0.7https://biojungbomoa.com/programs/nk-cell-therapy2026-09-02weekly0.7https://biojungbomoa.com/programs/bridging-therapy2026-09-02weekly0.7https://biojungbomoa.com/programs/aavrh-10hfxn-serotype-rh-10-adeno-associated-virus-aav-gene-transfer-vector-expressing-the-cdna-2026-09-02weekly0.7https://biojungbomoa.com/programs/sgn-30-anti-cd30-mab2026-09-02weekly0.7https://biojungbomoa.com/programs/antibody-drug-conjugate-therapy2026-09-02weekly0.7https://biojungbomoa.com/programs/allogeneic-natural-killer-cells2026-08-19weekly0.7https://biojungbomoa.com/programs/biological-tcr-t2026-07-13weekly0.7https://biojungbomoa.com/programs/l-asparaginase2026-07-13weekly0.7https://biojungbomoa.com/programs/smt-nk-inj-allogeneic-natural-killer-cell2026-07-12weekly0.7https://biojungbomoa.com/programs/ledipasvir-sofosbuvir2026-09-02weekly0.7https://biojungbomoa.com/programs/fecal-microbiota-transplantation2026-09-02weekly0.7https://biojungbomoa.com/programs/ado-trastuzumab-emtansine2026-09-02weekly0.7https://biojungbomoa.com/programs/sacituzumab-tirumotecan2026-09-02weekly0.7https://biojungbomoa.com/programs/n-803-il-15-superagonist2026-08-19weekly0.7https://biojungbomoa.com/programs/allogenic-nk-cells2026-07-18weekly0.7https://biojungbomoa.com/programs/proteasome-inhibitor2026-07-13weekly0.7https://biojungbomoa.com/programs/isotretinoin2026-07-13weekly0.7https://biojungbomoa.com/programs/daclatasvir-sofosbuvir2026-09-02weekly0.7https://biojungbomoa.com/programs/alt-8032026-09-02weekly0.7https://biojungbomoa.com/programs/antineoplastic-immune-cell2026-09-02weekly0.7https://biojungbomoa.com/programs/cytokine-induced-killer-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/cd19-car-t-arm2026-09-02weekly0.7https://biojungbomoa.com/programs/cytogenetic-analysis2026-09-02weekly0.7https://biojungbomoa.com/programs/cd19-chimeric-antigen-receptor-car-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/anti-bcma-car-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/anti-bcma-car-t2026-09-02weekly0.7https://biojungbomoa.com/programs/sacituzumab2026-09-02weekly0.7https://biojungbomoa.com/programs/brentuximabvedotin-bv2026-09-02weekly0.7https://biojungbomoa.com/programs/allogenic-nk-cells-infusion2026-08-19weekly0.7https://biojungbomoa.com/programs/cilostazol2026-07-18weekly0.7https://biojungbomoa.com/programs/t-dxd-trastuzmab-deruxtecan-ramucirumab2026-07-18weekly0.7https://biojungbomoa.com/programs/interferon-gamma2026-09-02weekly0.7https://biojungbomoa.com/programs/ts-12026-09-02weekly0.7https://biojungbomoa.com/programs/anti-cluster-of-differentiation-19-cd19-chimeric-antigen-receptor-car-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/anti-cluster-of-differentiation-19-cd19-car-pbl2026-08-19weekly0.7https://biojungbomoa.com/programs/lentiviral-gene-transfer2026-08-19weekly0.7https://biojungbomoa.com/programs/ny-eso-1-157-165-peptide-pulsed-autologous-dendritic-cell-vaccine2026-07-12weekly0.7https://biojungbomoa.com/programs/cik-cell-therapy2026-09-02weekly0.7https://biojungbomoa.com/programs/dendritic-cell-tumor-peptide-vaccine2026-09-02weekly0.7https://biojungbomoa.com/programs/fluorescence-in-situ-hybridization2026-09-02weekly0.7https://biojungbomoa.com/programs/quercetin2026-09-02weekly0.7https://biojungbomoa.com/programs/cd19-cd22-car-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/calcitonin-gene-related-peptide2026-07-18weekly0.7https://biojungbomoa.com/programs/tegafur-gimeracil-oteracil-potassium2026-07-18weekly0.7https://biojungbomoa.com/programs/intralipid2026-07-18weekly0.7https://biojungbomoa.com/programs/candesartan2026-07-13weekly0.7https://biojungbomoa.com/programs/eltrombopag2026-09-02weekly0.7https://biojungbomoa.com/programs/cd22-car2026-09-02weekly0.7https://biojungbomoa.com/programs/axicabtagene-ciloleucel2026-09-02weekly0.7https://biojungbomoa.com/programs/inotuzumab-ozogamicin2026-09-02weekly0.7https://biojungbomoa.com/programs/cd19-directed-car-t-cells2026-08-19weekly0.7https://biojungbomoa.com/programs/cd19-cd22-car-t2026-07-13weekly0.7https://biojungbomoa.com/programs/cd22-car-t2026-07-12weekly0.7https://biojungbomoa.com/programs/belantamab2026-09-02weekly0.7https://biojungbomoa.com/programs/polatuzumab2026-09-02weekly0.7https://biojungbomoa.com/programs/brentuximab-vedotin-sgn-352026-08-19weekly0.7https://biojungbomoa.com/programs/rc48-adc2026-08-19weekly0.7https://biojungbomoa.com/programs/pneumococcal-conjugate-vaccine-heptavalent2026-07-18weekly0.7https://biojungbomoa.com/programs/tcr-transduced-t-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/valaciclovir2026-09-02weekly0.7https://biojungbomoa.com/programs/autologous-activated-t-lymphocyte2026-07-18weekly0.7https://biojungbomoa.com/programs/brentuximab-vedotin-adcetris2026-07-13weekly0.7https://biojungbomoa.com/programs/crispr-cas92026-09-02weekly0.7https://biojungbomoa.com/programs/gene-modified-autologous-stem-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/lentiviral-vector-transduced-cd34-cells2026-09-02weekly0.7https://biojungbomoa.com/programs/cd7-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/enfortumab2026-09-02weekly0.55https://biojungbomoa.com/programs/loncastuximab-tesirine-anti-cd19-antibody-drug-conjugate2026-09-02weekly0.55https://biojungbomoa.com/programs/talimogene-laherparepvec2026-09-02weekly0.55https://biojungbomoa.com/programs/transduced-cd34-hematopoietic-stem-cell2026-09-02weekly0.55https://biojungbomoa.com/programs/palifermin2026-09-02weekly0.55https://biojungbomoa.com/programs/nk-cells-combined-monoclonal-antibodies2026-07-18weekly0.55https://biojungbomoa.com/programs/autologous-anti-bcma-chimeric-antigen-receptor-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/enfortumab-vedotin-and-pembrolizumab-ev-p2026-09-02weekly0.55https://biojungbomoa.com/programs/autoleucel-relmacabtagene-autoleucel2026-07-13weekly0.55https://biojungbomoa.com/programs/autologous-nk-cell-therapy2026-07-13weekly0.55https://biojungbomoa.com/programs/autologous-cytokine-induced-killer-cell2026-09-02weekly0.55https://biojungbomoa.com/programs/cell-function-identification2026-09-02weekly0.55https://biojungbomoa.com/programs/second-generation-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/dc-cik2026-08-19weekly0.55https://biojungbomoa.com/programs/chronic-myeloid-leukemia-nk-cell2026-07-18weekly0.55https://biojungbomoa.com/programs/autologous-natural-killer-cell-therapy2026-07-18weekly0.55https://biojungbomoa.com/programs/pentostatin2026-09-02weekly0.55https://biojungbomoa.com/programs/duvelisib2026-09-02weekly0.55https://biojungbomoa.com/programs/letermovir2026-09-02weekly0.55https://biojungbomoa.com/programs/tisagenlecleucel2026-09-02weekly0.55https://biojungbomoa.com/programs/tumor-specific-tcr-t-cells2026-07-18weekly0.55https://biojungbomoa.com/programs/histograft-a-bone-substitute-based-on-octacalcium-phosphate-ocp-and-plasmid-dna-encoding-vegfa-g2026-07-13weekly0.55https://biojungbomoa.com/programs/belinostat2026-07-12weekly0.55https://biojungbomoa.com/programs/cart-192026-09-02weekly0.55https://biojungbomoa.com/programs/combi2026-07-18weekly0.55https://biojungbomoa.com/programs/anti-mesothelin-chimeric-t-cell-receptor-car-transduced-peripheral-blood-lymphocytes-pbl2026-09-02weekly0.55https://biojungbomoa.com/programs/adv-hsv-tk-gene-therapy2026-09-02weekly0.55https://biojungbomoa.com/programs/immune-effector-cell-therapy2026-09-02weekly0.55https://biojungbomoa.com/programs/ifinatamab-deruxtecan-i-dxd2026-09-02weekly0.55https://biojungbomoa.com/programs/idov-immune-oncolytic-vaccinia-virus2026-09-02weekly0.55https://biojungbomoa.com/programs/hank2026-09-02weekly0.55https://biojungbomoa.com/programs/hyper-cvad2026-09-02weekly0.55https://biojungbomoa.com/programs/cd4-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/cd19-targeted-cart-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/imid-treatment2026-07-13weekly0.55https://biojungbomoa.com/programs/car-gpc3-t-cells2026-07-13weekly0.55https://biojungbomoa.com/programs/erwinase2026-07-13weekly0.55https://biojungbomoa.com/programs/chimeric-antigen-receptor-t-cells-car-t2026-09-02weekly0.55https://biojungbomoa.com/programs/sonrotoclax2026-08-19weekly0.55https://biojungbomoa.com/programs/ctl019-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/microarray-analysis2026-08-19weekly0.55https://biojungbomoa.com/programs/cd123-car-t-cells2026-07-13weekly0.55https://biojungbomoa.com/programs/ctl0192026-09-02weekly0.55https://biojungbomoa.com/programs/pelareorep2026-09-02weekly0.55https://biojungbomoa.com/programs/therapeutic-autologous-lymphocytes2026-09-02weekly0.55https://biojungbomoa.com/programs/ny-eso-1-c259-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/b7-h3-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/bcma-car-t2026-08-19weekly0.55https://biojungbomoa.com/programs/influenza-vaccine2026-09-02weekly0.55https://biojungbomoa.com/programs/cell-infusion2026-09-02weekly0.55https://biojungbomoa.com/programs/jcar017-lisocabtagene-maraleucel-2-dose-schedule2026-09-02weekly0.55https://biojungbomoa.com/programs/jcar017-lisocabtagene-maraleucel2026-09-02weekly0.55https://biojungbomoa.com/programs/cyclosporin-a2026-09-02weekly0.55https://biojungbomoa.com/programs/anti-cd19-car-nk-cells-kn55012026-09-02weekly0.55https://biojungbomoa.com/programs/ide-cel-bb21212026-09-02weekly0.55https://biojungbomoa.com/programs/car-t-cell-infusion2026-09-02weekly0.55https://biojungbomoa.com/programs/indomethacin2026-08-19weekly0.55https://biojungbomoa.com/programs/therapeutic-tumor-infiltrating-lymphocytes2026-08-19weekly0.55https://biojungbomoa.com/programs/nucleic-acid-sequencing2026-08-19weekly0.55https://biojungbomoa.com/programs/cd19-car-t-cell2026-08-19weekly0.55https://biojungbomoa.com/programs/car-t-cells-chimeric-antigen-receptor-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/anti-cd19-car2026-08-19weekly0.55https://biojungbomoa.com/programs/cd19-22-car-t-cells2026-07-18weekly0.55https://biojungbomoa.com/programs/car-t-infusion2026-09-02weekly0.55https://biojungbomoa.com/programs/immunochemotherapy2026-09-02weekly0.55https://biojungbomoa.com/programs/rh-il-15-5-days2026-09-02weekly0.55https://biojungbomoa.com/programs/rh-il-15-10-days2026-09-02weekly0.55https://biojungbomoa.com/programs/lymphodepleting2026-09-02weekly0.55https://biojungbomoa.com/programs/t-cell-receptor-engineered-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/leuprolide-acetate2026-09-02weekly0.55https://biojungbomoa.com/programs/goserelin-acetate2026-09-02weekly0.55https://biojungbomoa.com/programs/anti-cd19-car-nk-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/cellular-therapy2026-09-02weekly0.55https://biojungbomoa.com/programs/hs-10352-combined-with-fulvestrant-stage-22026-09-02weekly0.55https://biojungbomoa.com/programs/hs-10352-combined-with-fulvestrant-stage-12026-09-02weekly0.55https://biojungbomoa.com/programs/pcar-019-anti-cd19-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/cell-therapy-with-bispecific-antibodies2026-09-02weekly0.55https://biojungbomoa.com/programs/lisocabtagene-maraleucel2026-09-02weekly0.55https://biojungbomoa.com/programs/autologous-nk-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/peginterferon-alfa-2a2026-08-19weekly0.55https://biojungbomoa.com/programs/anti-protein-53-or-tumor-protein-53-p53-t-cell-receptor-transduced-peripheral-blood-lymphocytes2026-08-19weekly0.55https://biojungbomoa.com/programs/granulocyte-colony-stimulating-factor2026-08-19weekly0.55https://biojungbomoa.com/programs/escitalopram2026-08-19weekly0.55https://biojungbomoa.com/programs/citalopram2026-08-19weekly0.55https://biojungbomoa.com/programs/cd19-bcma-car-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/cd30-car-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/ap19032026-07-18weekly0.55https://biojungbomoa.com/programs/sulfonylurea2026-07-13weekly0.55https://biojungbomoa.com/programs/lapine-t-lymphocyte-immune-globulin2026-07-13weekly0.55https://biojungbomoa.com/programs/tumor-infiltrating-lymphocytes-infusion2026-09-02weekly0.55https://biojungbomoa.com/programs/lidocaine2026-09-02weekly0.55https://biojungbomoa.com/programs/gm103-part-b2026-09-02weekly0.55https://biojungbomoa.com/programs/gm103-part-a2026-09-02weekly0.55https://biojungbomoa.com/programs/donor-nk-cell-infusion2026-09-02weekly0.55https://biojungbomoa.com/programs/amoxicillin-clavulanate-potassium2026-09-02weekly0.55https://biojungbomoa.com/programs/high-dose-of-methotrexate2026-09-02weekly0.55https://biojungbomoa.com/programs/car-nk-cell2026-09-02weekly0.55https://biojungbomoa.com/programs/ebv-specific-ctls2026-09-02weekly0.55https://biojungbomoa.com/programs/tcr-t-therapy2026-09-02weekly0.55https://biojungbomoa.com/programs/pd1-pd-l1-checkpoint-inhibitor2026-09-02weekly0.55https://biojungbomoa.com/programs/therapeutic-cytotoxic-t-lymphocytes2026-09-02weekly0.55https://biojungbomoa.com/programs/zoledronate2026-09-02weekly0.55https://biojungbomoa.com/programs/flutamide2026-09-02weekly0.55https://biojungbomoa.com/programs/quadrivalent-inactivated-influenza-vaccine2026-09-02weekly0.55https://biojungbomoa.com/programs/autologous-cd4-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/enzyme-replacement-agent2026-09-02weekly0.55https://biojungbomoa.com/programs/methylphenidate2026-09-02weekly0.55https://biojungbomoa.com/programs/dc-vaccine2026-09-02weekly0.55https://biojungbomoa.com/programs/glp-1-receptor-agonist2026-09-02weekly0.55https://biojungbomoa.com/programs/enfuvirtide2026-09-02weekly0.55https://biojungbomoa.com/programs/midostaurin2026-09-02weekly0.55https://biojungbomoa.com/programs/moxifloxacin2026-09-02weekly0.55https://biojungbomoa.com/programs/saliva-samples2026-09-02weekly0.55https://biojungbomoa.com/programs/targeted-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/t-cells-or-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/gene-modified-anti-il1rap-chimeric-antigen-receptor-t-cells-2-5-10-8-second-dose-group2026-09-02weekly0.55https://biojungbomoa.com/programs/dose-group-62026-09-02weekly0.55https://biojungbomoa.com/programs/dose-group-52026-09-02weekly0.55https://biojungbomoa.com/programs/dose-group-42026-09-02weekly0.55https://biojungbomoa.com/programs/dose-group-32026-09-02weekly0.55https://biojungbomoa.com/programs/dose-group-22026-09-02weekly0.55https://biojungbomoa.com/programs/cd70-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/fentanyl-citrate2026-08-19weekly0.55https://biojungbomoa.com/programs/autologous-nk-cell2026-08-19weekly0.55https://biojungbomoa.com/programs/dapsone2026-08-19weekly0.55https://biojungbomoa.com/programs/nk-cells-infusion2026-08-19weekly0.55https://biojungbomoa.com/programs/cellular-therapy-product2026-08-19weekly0.55https://biojungbomoa.com/programs/vaccine-therapy2026-08-19weekly0.55https://biojungbomoa.com/programs/autologous-car-t2026-08-19weekly0.55https://biojungbomoa.com/programs/gene-analysis2026-08-19weekly0.55https://biojungbomoa.com/programs/pralatrexate2026-08-19weekly0.55https://biojungbomoa.com/programs/comparative-genomic-hybridization2026-08-19weekly0.55https://biojungbomoa.com/programs/an-antibody-drug-conjugate2026-08-19weekly0.55https://biojungbomoa.com/programs/autologous-immune-cells2026-07-13weekly0.55https://biojungbomoa.com/programs/autologous-hematopoietic-stem-cell-infusion2026-07-13weekly0.55https://biojungbomoa.com/programs/autologous-cd19-targeted-car-t-cells2026-07-13weekly0.55https://biojungbomoa.com/programs/aspirin-plus-clopidogrel2026-07-13weekly0.55https://biojungbomoa.com/programs/anti-cd20-mab2026-07-13weekly0.55https://biojungbomoa.com/programs/alhydrogel-adjuvant2026-07-13weekly0.55https://biojungbomoa.com/programs/adjuvant-im-therapy2026-07-13weekly0.55https://biojungbomoa.com/programs/risdiplam2026-09-02weekly0.55https://biojungbomoa.com/programs/recombinant-human-adenovirus-type-52026-09-02weekly0.55https://biojungbomoa.com/programs/oncolytic-virus2026-09-02weekly0.55https://biojungbomoa.com/programs/teniposide2026-09-02weekly0.55https://biojungbomoa.com/programs/vay7362026-09-02weekly0.55https://biojungbomoa.com/programs/interleukin-nk-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/hu3f82026-09-02weekly0.55https://biojungbomoa.com/programs/allogeneic-natural-killer-cell-line-nk-922026-09-02weekly0.55https://biojungbomoa.com/programs/car-nk-cd19-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/transplant-conditioning-with-mobilization-only2026-09-02weekly0.55https://biojungbomoa.com/programs/anti-mage-a3-human-leukocyte-antigen-serotype-within-hla-a-a-serotype-group-hla-a-01-restricted-2026-09-02weekly0.55https://biojungbomoa.com/programs/genetically-engineered-t-cell-receptors2026-09-02weekly0.55https://biojungbomoa.com/programs/idecabtagene-vicleucel2026-09-02weekly0.55https://biojungbomoa.com/programs/liso-cel2026-09-02weekly0.55https://biojungbomoa.com/programs/efineptakin-alfa2026-09-02weekly0.55https://biojungbomoa.com/programs/infusion-of-axicabtagene-ciloleucel2026-09-02weekly0.55https://biojungbomoa.com/programs/o6-benzylguanine2026-09-02weekly0.55https://biojungbomoa.com/programs/sodium-acetate2026-09-02weekly0.55https://biojungbomoa.com/programs/ifn-gamma2026-09-02weekly0.55https://biojungbomoa.com/programs/kanamycin2026-09-02weekly0.55https://biojungbomoa.com/programs/isoniazid2026-09-02weekly0.55https://biojungbomoa.com/programs/pyrazinamide2026-09-02weekly0.55https://biojungbomoa.com/programs/levofloxacin2026-09-02weekly0.55https://biojungbomoa.com/programs/bedaquiline2026-09-02weekly0.55https://biojungbomoa.com/programs/linezolid2026-09-02weekly0.55https://biojungbomoa.com/programs/anti-cd22-car2026-09-02weekly0.55https://biojungbomoa.com/programs/gd2-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/car-t-cells-targeting-cd19-and-cd222026-09-02weekly0.55https://biojungbomoa.com/programs/cart192026-09-02weekly0.55https://biojungbomoa.com/programs/cd19-cd20-car-t-cell-infusion2026-09-02weekly0.55https://biojungbomoa.com/programs/anti-cd19-car-nk2026-09-02weekly0.55https://biojungbomoa.com/programs/pertuzumab-trastuzumab-emtansine2026-09-02weekly0.55https://biojungbomoa.com/programs/t-dm1-and-pertuzumab2026-09-02weekly0.55https://biojungbomoa.com/programs/nk-cells-pd-l-1-inhibitor-pemetrexed-as-first-line-maintenance-therapy2026-08-19weekly0.55https://biojungbomoa.com/programs/donor-derived-natural-killer-cell2026-08-19weekly0.55https://biojungbomoa.com/programs/donor-derived-nk-cell-infusion2026-08-19weekly0.55https://biojungbomoa.com/programs/cik-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/amniotic-epithelial-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/degarelix2026-08-19weekly0.55https://biojungbomoa.com/programs/anti-bcma-cd19-car-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/t-cell-injection-targeting-cd19-chimeric-antigen-receptor2026-08-19weekly0.55https://biojungbomoa.com/programs/chimeric-antigen-receptor-gene-modified-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/gene-modified-t-cells-targeted2026-08-19weekly0.55https://biojungbomoa.com/programs/bcma-cart-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/autologous-bcma-car-t-cells-and-cd19-car-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/autologous-bcma-targeting-car-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/gd2-car-t-cells2026-07-13weekly0.55https://biojungbomoa.com/programs/umbilical-cord-blood-nk-cells2026-07-12weekly0.55https://biojungbomoa.com/programs/anti-cd19-car-vector-transduced-t-cells2026-07-12weekly0.55https://biojungbomoa.com/programs/autologous-dendritic-cell-vaccination2026-07-12weekly0.55https://biojungbomoa.com/programs/wt1-vaccine2026-07-12weekly0.55https://biojungbomoa.com/programs/ny-eso-1-vaccine2026-07-12weekly0.55https://biojungbomoa.com/programs/pamidronate-disodium2026-07-12weekly0.55https://biojungbomoa.com/programs/l-asparaginase-erwinia-asparaginase2026-07-12weekly0.55https://biojungbomoa.com/programs/gene-rearrangement-analysis2026-07-12weekly0.55https://biojungbomoa.com/programs/salivary-collection2026-07-12weekly0.55https://biojungbomoa.com/programs/peptide-specific-dendritic-cell2026-07-12weekly0.55https://biojungbomoa.com/programs/gemtuzumab-ozogamicin-mylotarg2026-07-12weekly0.55https://biojungbomoa.com/programs/temozolomide-surgery-radiotherapy2026-07-04weekly0.55https://biojungbomoa.com/programs/anti-cd19-car-t-cell-therapy2026-07-04weekly0.55https://biojungbomoa.com/programs/axi-cel2026-09-02weekly0.55https://biojungbomoa.com/programs/xpo1-inhibitor2026-07-12weekly0.55https://biojungbomoa.com/programs/autologous-cd34-cells-genetically-modified2026-09-02weekly0.55https://biojungbomoa.com/programs/becotatug-vedotin2026-09-02weekly0.55https://biojungbomoa.com/programs/fast-car-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/linperlisib2026-07-12weekly0.55https://biojungbomoa.com/programs/anti-cd19-cd22-car-t-cells2026-07-12weekly0.55https://biojungbomoa.com/programs/jnj-682845282026-09-02weekly0.55https://biojungbomoa.com/programs/rintatolimod2026-09-02weekly0.55https://biojungbomoa.com/programs/fam-trastuzumab-deruxtecan-nxki-tdxd2026-09-02weekly0.55https://biojungbomoa.com/programs/bcma-cd19-dual-target-car-t2026-08-19weekly0.55https://biojungbomoa.com/programs/drug-disitamab-vedotin2026-09-02weekly0.55https://biojungbomoa.com/programs/avacopan2026-07-13weekly0.55https://biojungbomoa.com/programs/allogeneic-donor-derived-nk-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/defibrotide2026-09-02weekly0.55https://biojungbomoa.com/programs/ex-vivo-expanded-autologous-il-8-receptor-cxcr2-modified-cd70-car-8r-70car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/consolidation-with-brentuximab-vedotin2026-08-19weekly0.55https://biojungbomoa.com/programs/allogeneic-invariant-natural-killer-t-inkt-cells-agent-7972026-07-04weekly0.55https://biojungbomoa.com/programs/oncorine-h1012026-09-02weekly0.55https://biojungbomoa.com/programs/sacituzumab-govitecan-trastuzumab-deruxtecan2026-09-02weekly0.55https://biojungbomoa.com/programs/alpha-beta-t-cell-depleted-hematopoietic-stem-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/brentuximab-vedotin-induction2026-07-12weekly0.55https://biojungbomoa.com/programs/vigil2026-07-04weekly0.55https://biojungbomoa.com/programs/sd-1012026-07-04weekly0.55https://biojungbomoa.com/programs/h1012026-09-02weekly0.55https://biojungbomoa.com/programs/dual-target-car-nk-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/velaglucerase-alfa2026-09-02weekly0.55https://biojungbomoa.com/programs/anti-mesothelin-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/her2-trastuzumab-deruxtecan-pertuzumab2026-09-02weekly0.55https://biojungbomoa.com/programs/vic-trastuzumab-duocarmazine2026-08-19weekly0.55https://biojungbomoa.com/programs/allogenic-expanded-natural-killer-cells-allonk12026-07-12weekly0.55https://biojungbomoa.com/programs/18f-rhpsma-7-32026-07-12weekly0.55https://biojungbomoa.com/programs/systemic-therapy-as-selected-by-the-investigator2026-07-04weekly0.55https://biojungbomoa.com/programs/lymphokine-activated-killer-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/cd3-cd56-natural-killer-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/relmacabtagene-autoleucel-relma-cel2026-09-02weekly0.55https://biojungbomoa.com/programs/lcar-b38m-car-t-cell2026-09-02weekly0.55https://biojungbomoa.com/programs/relma-cel2026-09-02weekly0.55https://biojungbomoa.com/programs/gc012f2026-09-02weekly0.55https://biojungbomoa.com/programs/genetic-determinants-analysis2026-08-19weekly0.55https://biojungbomoa.com/programs/relmacabtagene-autoleucel2026-08-19weekly0.55https://biojungbomoa.com/programs/etbx-0612026-09-02weekly0.55https://biojungbomoa.com/programs/recombinant-oncolytic-herpes-simplex-virus-type-1-r1302026-09-02weekly0.55https://biojungbomoa.com/programs/tcr-redirected-t-cells2026-07-12weekly0.55https://biojungbomoa.com/programs/etbx-0512026-09-02weekly0.55https://biojungbomoa.com/programs/etbx-0112026-09-02weekly0.55https://biojungbomoa.com/programs/ibi3102026-09-02weekly0.55https://biojungbomoa.com/programs/tebentafusp2026-09-02weekly0.55https://biojungbomoa.com/programs/single-cell-cloning2026-09-02weekly0.55https://biojungbomoa.com/programs/jcar0172026-09-02weekly0.55https://biojungbomoa.com/programs/brexucabtagene-autoleucel-kte-x192026-09-02weekly0.55https://biojungbomoa.com/programs/brexucabtagene-autoleucel2026-09-02weekly0.55https://biojungbomoa.com/programs/cd33-car-t-cell-infusion2026-08-19weekly0.55https://biojungbomoa.com/programs/jx-5942026-09-02weekly0.55https://biojungbomoa.com/programs/recombinant-vaccinia-gm-csf-rac-vac-gm-csf-jx-5942026-09-02weekly0.55https://biojungbomoa.com/programs/expanded-haploidentical-natural-killer-cells-nkaes2026-09-02weekly0.55https://biojungbomoa.com/programs/gi-63012026-09-02weekly0.55https://biojungbomoa.com/programs/umbilical-cord-blood-derived-natural-killer-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/hpc-a-infusion2026-09-02weekly0.55https://biojungbomoa.com/programs/fgfr-inhibitor-azd45472026-09-02weekly0.55https://biojungbomoa.com/programs/cd19-redirected-autologous-t-cells-ctl019-or-ctl119-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/nt-i72026-09-02weekly0.55https://biojungbomoa.com/programs/ab-1009-gaa-gene2026-09-02weekly0.55https://biojungbomoa.com/programs/targeted-cea-car-t2026-09-02weekly0.55https://biojungbomoa.com/programs/loss-of-heterozygosity-analysis2026-08-19weekly0.55https://biojungbomoa.com/programs/cea-targeted-car-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/ad5cmv-p53-gene2026-07-04weekly0.55https://biojungbomoa.com/programs/pexa-vec2026-09-02weekly0.55https://biojungbomoa.com/programs/pexastimogene-devacirepvec-pexa-vec2026-09-02weekly0.55https://biojungbomoa.com/programs/ril-22026-09-02weekly0.55https://biojungbomoa.com/programs/neoantigen-dna-vaccine2026-09-02weekly0.55https://biojungbomoa.com/programs/gvax-pancreatic-cancer-vaccine2026-09-02weekly0.55https://biojungbomoa.com/programs/gc1012026-09-02weekly0.55https://biojungbomoa.com/programs/genetically-engineered-nk-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/adult-differentiated-autologous-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/t-dxd-pertuzumab2026-09-02weekly0.55https://biojungbomoa.com/programs/cnct192026-08-19weekly0.55https://biojungbomoa.com/programs/tislelizumab-disitamab-vedotin2026-08-19weekly0.55https://biojungbomoa.com/programs/disitamab-vedotin-tislelizumab2026-07-12weekly0.55https://biojungbomoa.com/programs/disitamab-vedotin-combined-with-tislelizumab2026-07-12weekly0.55https://biojungbomoa.com/programs/disitamab-vedotin-combined-with-toripalimab2026-07-12weekly0.55https://biojungbomoa.com/programs/tas-1202026-07-04weekly0.55https://biojungbomoa.com/programs/standard-therapeutic-dli2026-09-02weekly0.55https://biojungbomoa.com/programs/ucb-nk-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/pd-1-knockout-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/ethionamide2026-09-02weekly0.55https://biojungbomoa.com/programs/golcadomide2026-09-02weekly0.55https://biojungbomoa.com/programs/allogeneic-anti-cd7-car-t-cells-beam-2012026-09-02weekly0.55https://biojungbomoa.com/programs/coxsackievirus-a212026-09-02weekly0.55https://biojungbomoa.com/programs/cva212026-09-02weekly0.55https://biojungbomoa.com/programs/coxsackievirus-a21-cva212026-09-02weekly0.55https://biojungbomoa.com/programs/gi-62072026-09-02weekly0.55https://biojungbomoa.com/programs/cd3-cd19-natural-killer-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/adeno-associated-viral-with-human-factor-ix2026-09-02weekly0.55https://biojungbomoa.com/programs/ino-90122026-09-02weekly0.55https://biojungbomoa.com/programs/memory-like-natural-killer-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/cd22-cd19-dual-target-car-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/cc-1222026-08-19weekly0.55https://biojungbomoa.com/programs/baff-car-t2026-07-13weekly0.55https://biojungbomoa.com/programs/4scar-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/jx-594-recombinant-vaccinia-virus-tk-deletion-plus-gm-csf2026-09-02weekly0.55https://biojungbomoa.com/programs/oh2-oncolytic-virus2026-09-02weekly0.55https://biojungbomoa.com/programs/hf102026-09-02weekly0.55https://biojungbomoa.com/programs/vusolimogene-oderparepvec-rp12026-09-02weekly0.55https://biojungbomoa.com/programs/tbi-1401-hf102026-09-02weekly0.55https://biojungbomoa.com/programs/nkg2d-car-nk2026-09-02weekly0.55https://biojungbomoa.com/programs/ebv-tcr-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/autologous-cd8-melanoma-specific-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/vegf-plasmid2026-09-02weekly0.55https://biojungbomoa.com/programs/jwcar0292026-09-02weekly0.55https://biojungbomoa.com/programs/peg-ada2026-09-02weekly0.55https://biojungbomoa.com/programs/injection-of-aav2-rep1-10e11-vg2026-09-02weekly0.55https://biojungbomoa.com/programs/kyv-1012026-09-02weekly0.55https://biojungbomoa.com/programs/anti-cd22-car-transduced-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/tisotumab-vedotin-humax-tf-adc2026-09-02weekly0.55https://biojungbomoa.com/programs/anti-cd30-car-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/autologous-humanized-anti-cd19-car-t-cell-therapy-hucart192026-08-19weekly0.55https://biojungbomoa.com/programs/anti-cea-car-t2026-08-19weekly0.55https://biojungbomoa.com/programs/telisotuzumab-adizutecan2026-07-13weekly0.55https://biojungbomoa.com/programs/rc48-adc-and-js0012026-07-12weekly0.55https://biojungbomoa.com/programs/disitamab-vedotin-and-cisplatin2026-07-12weekly0.55https://biojungbomoa.com/programs/t-cell-infusion-agent-targeting-bcma-chimeric-antigen-receptor2026-07-04weekly0.55https://biojungbomoa.com/programs/polio-rhinovirus-recombinant-pvsripo2026-09-02weekly0.55https://biojungbomoa.com/programs/t30112026-09-02weekly0.55https://biojungbomoa.com/programs/oncolytic-measles-virus-encoding-thyroidal-sodium-iodide-symporter2026-09-02weekly0.55https://biojungbomoa.com/programs/mv-nis2026-09-02weekly0.55https://biojungbomoa.com/programs/cytokine-induced-memory-like-natural-killer-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/rtl1000-recombinant-t-cell-receptor-ligand2026-09-02weekly0.55https://biojungbomoa.com/programs/cdx-11402026-09-02weekly0.55https://biojungbomoa.com/programs/alt-8012026-09-02weekly0.55https://biojungbomoa.com/programs/bpx-501-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/kte-x192026-09-02weekly0.55https://biojungbomoa.com/programs/genetically-engineered-hematopoietic-stem-progenitor-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/anti-cd33-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/polatuzumab-vedotin-rituximab-lenalidomide2026-09-02weekly0.55https://biojungbomoa.com/programs/ciml-nk-cell-therapy2026-08-19weekly0.55https://biojungbomoa.com/programs/anti-meso-car-t-cells2026-07-12weekly0.55https://biojungbomoa.com/programs/drugs-and-anti-cd19-car-transduced-t-cells2026-07-04weekly0.55https://biojungbomoa.com/programs/cg00702026-09-02weekly0.55https://biojungbomoa.com/programs/e7-tcr2026-09-02weekly0.55https://biojungbomoa.com/programs/e7-tcr-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/ccr5-gene-modification2026-09-02weekly0.55https://biojungbomoa.com/programs/pd-1-knockout-engineered-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/bb21212026-09-02weekly0.55https://biojungbomoa.com/programs/kyv-101-anti-cd19-car-t-cell-therapy2026-09-02weekly0.55https://biojungbomoa.com/programs/anti-gpc3-car-t2026-09-02weekly0.55https://biojungbomoa.com/programs/rapcabtagene-autoleucel-ytb3232026-09-02weekly0.55https://biojungbomoa.com/programs/datopotamab-deruxtecan-durvalumab2026-09-02weekly0.55https://biojungbomoa.com/programs/autologous-tumor-infiltrating-lymphocytes-ln-1452026-08-19weekly0.55https://biojungbomoa.com/programs/im19-car-t2026-08-19weekly0.55https://biojungbomoa.com/programs/19-28z-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/astx6602026-07-13weekly0.55https://biojungbomoa.com/programs/becotatug-vedotin-and-pucotenlimab2026-07-12weekly0.55https://biojungbomoa.com/programs/oncolytic-virus-h1012026-09-02weekly0.55https://biojungbomoa.com/programs/autologous-immune-enhancement-therapy-aiet-for-cancer-patients2026-09-02weekly0.55https://biojungbomoa.com/programs/super-nk-cell2026-09-02weekly0.55https://biojungbomoa.com/programs/dual-target-car-nk-cell-product2026-09-02weekly0.55https://biojungbomoa.com/programs/yy-20394-treatment2026-09-02weekly0.55https://biojungbomoa.com/programs/t-cell-depleted-hpc-transplant2026-09-02weekly0.55https://biojungbomoa.com/programs/hucart19-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/targeted-activated-dendritic-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/disitamab-vedotin-combined-with-sintilimab2026-09-02weekly0.55https://biojungbomoa.com/programs/zilovertamab-vedotin2026-09-02weekly0.55https://biojungbomoa.com/programs/hucart192026-08-19weekly0.55https://biojungbomoa.com/programs/anti-cd19-car-t-cells-preparation2026-07-13weekly0.55https://biojungbomoa.com/programs/aav8haat-avl2026-07-13weekly0.55https://biojungbomoa.com/programs/zamtocabtagene-autoleucel-mb-cart2019-12026-07-13weekly0.55https://biojungbomoa.com/programs/claudin18-2-targeted-car-t-cells2026-07-12weekly0.55https://biojungbomoa.com/programs/anti-bcma-car-nk-cells2026-07-12weekly0.55https://biojungbomoa.com/programs/hank-for-infusion2026-07-04weekly0.55https://biojungbomoa.com/programs/vpriv2026-07-04weekly0.55https://biojungbomoa.com/programs/oncolytic-adenovirus-h1012026-09-02weekly0.55https://biojungbomoa.com/programs/dnx-24012026-09-02weekly0.55https://biojungbomoa.com/programs/tcr-like-car-t2026-09-02weekly0.55https://biojungbomoa.com/programs/ctx0012026-09-02weekly0.55https://biojungbomoa.com/programs/mb-1022026-09-02weekly0.55https://biojungbomoa.com/programs/treg-cd34-hspc-orca-t2026-09-02weekly0.55https://biojungbomoa.com/programs/azd01202026-09-02weekly0.55https://biojungbomoa.com/programs/rd13-02-cell-infusion2026-09-02weekly0.55https://biojungbomoa.com/programs/ex-vivo-expanded-t-cell-infusion2026-09-02weekly0.55https://biojungbomoa.com/programs/baffr-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/belantamab-mafodotin-blmf2026-09-02weekly0.55https://biojungbomoa.com/programs/raludotatug-deruxtecan-r-dxd2026-09-02weekly0.55https://biojungbomoa.com/programs/glembatumumab-vedotin2026-09-02weekly0.55https://biojungbomoa.com/programs/ink-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/rivogenlecleucel2026-08-19weekly0.55https://biojungbomoa.com/programs/fully-human-bcma-chimeric-antigen-receptor-autologous-t-cell-injection-eque-cel2026-08-19weekly0.55https://biojungbomoa.com/programs/rapcabtagene-autoleucel2026-08-19weekly0.55https://biojungbomoa.com/programs/cart-egfr2026-08-19weekly0.55https://biojungbomoa.com/programs/chromosomal-translocation-analysis2026-07-12weekly0.55https://biojungbomoa.com/programs/morphine-chlorhydrate2026-07-04weekly0.55https://biojungbomoa.com/programs/oncolytic-virus-plus-anti-pd1-and-chemotherapy2026-09-02weekly0.55https://biojungbomoa.com/programs/obp-3012026-09-02weekly0.55https://biojungbomoa.com/programs/recombinant-oncolytic-herpes-simplex-virus-type-i-r1302026-09-02weekly0.55https://biojungbomoa.com/programs/gl-onc12026-09-02weekly0.55https://biojungbomoa.com/programs/cd45ra-depleted-dli2026-09-02weekly0.55https://biojungbomoa.com/programs/letetresgene-autoleucel-gsk33777942026-09-02weekly0.55https://biojungbomoa.com/programs/auto12026-09-02weekly0.55https://biojungbomoa.com/programs/depatuxizumab-mafodotin2026-09-02weekly0.55https://biojungbomoa.com/programs/snk01-super-natural-killer-cells-012026-08-19weekly0.55https://biojungbomoa.com/programs/clostridium-butyricum-cbm-588-probiotic-strain2026-08-19weekly0.55https://biojungbomoa.com/programs/obecabtagene-autoleucel-obe-cel2026-08-19weekly0.55https://biojungbomoa.com/programs/il-15-armored-car-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/autologous-cd19-cd22-cd20-chimeric-antigen-receptor-t-cells2026-07-13weekly0.55https://biojungbomoa.com/programs/anti-cd123-lv-redirected-t-cells-cart1232026-07-13weekly0.55https://biojungbomoa.com/programs/ad5-ycd-muttksr39rep-adp-adenovirus-and-fractionated-stereotactic-radiosurgery-fsrs2026-07-13weekly0.55https://biojungbomoa.com/programs/snk012026-07-04weekly0.55https://biojungbomoa.com/programs/antibody-drug-conjugate-chemotherapeutic2026-05-31weekly0.55https://biojungbomoa.com/programs/her2bi-armed-activated-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/cgtg-1022026-09-02weekly0.55https://biojungbomoa.com/programs/oncos-1022026-09-02weekly0.55https://biojungbomoa.com/programs/cd33-car-nk-cell2026-09-02weekly0.55https://biojungbomoa.com/programs/ab-1012026-09-02weekly0.55https://biojungbomoa.com/programs/mrna-hbv-tcr-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/exa-cel2026-09-02weekly0.55https://biojungbomoa.com/programs/talen2026-09-02weekly0.55https://biojungbomoa.com/programs/e77772026-09-02weekly0.55https://biojungbomoa.com/programs/lentiglobin-bb305-drug-product2026-09-02weekly0.55https://biojungbomoa.com/programs/peg-ada-ert2026-09-02weekly0.55https://biojungbomoa.com/programs/epcam-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/advm-0222026-09-02weekly0.55https://biojungbomoa.com/programs/mb-cart19-12026-09-02weekly0.55https://biojungbomoa.com/programs/descartes-082026-09-02weekly0.55https://biojungbomoa.com/programs/syd985-vic-trastuzumab-duocarmazine2026-09-02weekly0.55https://biojungbomoa.com/programs/raludotatug-deruxtecan2026-09-02weekly0.55https://biojungbomoa.com/programs/technetium-tc-99m-sodium-pertechnetate2026-08-19weekly0.55https://biojungbomoa.com/programs/umbilical-cord-blood-derived-lymphocyte-therapy2026-08-19weekly0.55https://biojungbomoa.com/programs/zeprumetostat2026-08-19weekly0.55https://biojungbomoa.com/programs/anti-muc1-car-t-cells2026-07-12weekly0.55https://biojungbomoa.com/programs/autologous-car19-t-lymphocytes2026-07-12weekly0.55https://biojungbomoa.com/programs/atlcar-cd30-t-cells2026-07-12weekly0.55https://biojungbomoa.com/programs/hu14-18k322a2026-07-12weekly0.55https://biojungbomoa.com/programs/plenadren2026-07-12weekly0.55https://biojungbomoa.com/programs/allogeneic-gm-csf-secreting-breast-cancer-vaccine2026-09-02weekly0.55https://biojungbomoa.com/programs/oav1012026-09-02weekly0.55https://biojungbomoa.com/programs/vsv-ifn-nis2026-09-02weekly0.55https://biojungbomoa.com/programs/tilt-1232026-09-02weekly0.55https://biojungbomoa.com/programs/vcn-012026-09-02weekly0.55https://biojungbomoa.com/programs/lmp1-2-ctls-alci-expansion-group-c2026-09-02weekly0.55https://biojungbomoa.com/programs/lmp1-2-ctls-alci-expansion-group-b2026-09-02weekly0.55https://biojungbomoa.com/programs/lmp1-2-ctls-alci-expansion-group-a2026-09-02weekly0.55https://biojungbomoa.com/programs/lmp1-2-ctls-alci-group-c2026-09-02weekly0.55https://biojungbomoa.com/programs/lmp1-2-ctls-alci-group-b2026-09-02weekly0.55https://biojungbomoa.com/programs/lmp1-2-ctls-alci-group-a2026-09-02weekly0.55https://biojungbomoa.com/programs/individual-patient-tcr-transduced-pbl2026-09-02weekly0.55https://biojungbomoa.com/programs/otl-1012026-09-02weekly0.55https://biojungbomoa.com/programs/infusion-of-autologous-cryopreserved-efs-ada-lv-cd34-cells-otl-1012026-09-02weekly0.55https://biojungbomoa.com/programs/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-t-lymphocytes2026-09-02weekly0.55https://biojungbomoa.com/programs/alipogene-tiparvovec-amt-011-human-lpl-s447x2026-09-02weekly0.55https://biojungbomoa.com/programs/aav2-gdnf2026-09-02weekly0.55https://biojungbomoa.com/programs/aav2-gdnf-gene-therapy2026-09-02weekly0.55https://biojungbomoa.com/programs/tak-9812026-09-02weekly0.55https://biojungbomoa.com/programs/c-car0882026-09-02weekly0.55https://biojungbomoa.com/programs/prizloncabtagene-autoleucel2026-09-02weekly0.55https://biojungbomoa.com/programs/ct103a2026-09-02weekly0.55https://biojungbomoa.com/programs/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-enriched-t-lymphocytes2026-09-02weekly0.55https://biojungbomoa.com/programs/cd19-t-hank2026-09-02weekly0.55https://biojungbomoa.com/programs/mirvetuximab-soravtansine-plus-bevacizumab2026-09-02weekly0.55https://biojungbomoa.com/programs/belantamab-mafodotin-lyophilized-powder2026-09-02weekly0.55https://biojungbomoa.com/programs/sonesitatug-vedotin2026-09-02weekly0.55https://biojungbomoa.com/programs/tcr-mage-a4-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/dimerizer-drug-ap19032026-08-19weekly0.55https://biojungbomoa.com/programs/c-car0112026-08-19weekly0.55https://biojungbomoa.com/programs/autologous-humanized-anti-cd22-car-t-cell-therapy-cart22-65s2026-08-19weekly0.55https://biojungbomoa.com/programs/allo-6472026-08-19weekly0.55https://biojungbomoa.com/programs/t-cell-injection-targeting-cd7-chimeric-antigen-receptor2026-08-19weekly0.55https://biojungbomoa.com/programs/anti-her2-car-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/caba-2012026-07-13weekly0.55https://biojungbomoa.com/programs/disitamab-vedotin-and-gemcitabine2026-07-12weekly0.55https://biojungbomoa.com/programs/disitamab-vedotin-plus-cadonilimab2026-07-12weekly0.55https://biojungbomoa.com/programs/zamtocabtagene-autoleucel2026-07-04weekly0.55https://biojungbomoa.com/programs/neoadjuvant-and-adjuvant-becotatug-vedotin2026-07-04weekly0.55https://biojungbomoa.com/programs/csl222-aav5-hfixco-padua2026-09-02weekly0.55https://biojungbomoa.com/programs/g2072026-09-02weekly0.55https://biojungbomoa.com/programs/oncolytic-virus-vrt1062026-09-02weekly0.55https://biojungbomoa.com/programs/enadenotucirev2026-09-02weekly0.55https://biojungbomoa.com/programs/cd45ra-depleted-hpc-transplant2026-09-02weekly0.55https://biojungbomoa.com/programs/autologous-ny-eso-1-specific-cd8-positive-t-lymphocytes2026-09-02weekly0.55https://biojungbomoa.com/programs/wt1-tcr-transduced-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/tbi-13012026-09-02weekly0.55https://biojungbomoa.com/programs/afp-specific-t-cell-receptor-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/mesothelin-directed-car-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/anti-cd20-car-vector-transduced-autologous-t-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/sscart-192026-09-02weekly0.55https://biojungbomoa.com/programs/cd19-car-dnt-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/aav-rpe652026-09-02weekly0.55https://biojungbomoa.com/programs/adeno-associated-virus-vector-expressing-a-human-rpgr-gene2026-09-02weekly0.55https://biojungbomoa.com/programs/ixo-vec2026-09-02weekly0.55https://biojungbomoa.com/programs/dual-specificity-cd19-and-cd22-car-t-cell-immunotherapy2026-09-02weekly0.55https://biojungbomoa.com/programs/cart22-cells2026-09-02weekly0.55https://biojungbomoa.com/programs/ft5382026-09-02weekly0.55https://biojungbomoa.com/programs/ladiratuzumab-vedotin2026-09-02weekly0.55https://biojungbomoa.com/programs/trastuzumab-emtansine-kadcyla2026-09-02weekly0.55https://biojungbomoa.com/programs/tcr-alpha-beta-cd19-depleted-haploidentical-hematopoietic-progenitor-cell-graft2026-08-19weekly0.55https://biojungbomoa.com/programs/rjmty19-cd19-car-dnt-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/autologous-cd34-cells-transduced-with-wasp-lentiviral-vector2026-08-19weekly0.55https://biojungbomoa.com/programs/cd19-car-t2-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/bcma-cd19-ccar-t-cells2026-08-19weekly0.55https://biojungbomoa.com/programs/sgn-15-cbr96-doxorubicin-immunoconjugate2026-08-19weekly0.55https://biojungbomoa.com/programs/ondansetron2026-07-12weekly0.55https://biojungbomoa.com/programs/cdh17-car-t2026-07-12weekly0.55https://biojungbomoa.com/programs/sigvotatug-vedotin2026-07-04weekly0.55https://biojungbomoa.com/programs/4scar-gd22026-05-31weekly0.55